Does RILUZOLE Cause Interstitial lung disease? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Interstitial lung disease have been filed in association with RILUZOLE (Teglutik). This represents 2.3% of all adverse event reports for RILUZOLE.
33
Reports of Interstitial lung disease with RILUZOLE
2.3%
of all RILUZOLE reports
1
Deaths
10
Hospitalizations
How Dangerous Is Interstitial lung disease From RILUZOLE?
Of the 33 reports, 1 (3.0%) resulted in death, 10 (30.3%) required hospitalization, and 1 (3.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for RILUZOLE.
What Other Side Effects Does RILUZOLE Cause?
Death (238)
Nausea (111)
Diarrhoea (94)
Dizziness (60)
Drug ineffective (58)
Disease progression (57)
Fatigue (56)
Off label use (52)
Abdominal discomfort (50)
Hypoaesthesia oral (50)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which RILUZOLE Alternatives Have Lower Interstitial lung disease Risk?
RILUZOLE vs RIMABOTULINUMTOXINB
RILUZOLE vs RIMEGEPANT
RILUZOLE vs RIOCIGUAT
RILUZOLE vs RIPRETINIB
RILUZOLE vs RISANKIZUMAB